Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for IMNM

Stock NameImmunome Inc
TickerIMNM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45257U1088

Show aggregate IMNM holdings

News associated with IMNM

Analysts Set Immunome, Inc. (NASDAQ:IMNM) PT at $22.50
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has earned an average rating of “Buy” from the eight research firms that are presently covering the stock, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the stock in the […] - 2025-09-05 02:36:50
Guggenheim Reaffirms Buy Rating for Immunome (NASDAQ:IMNM)
Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Guggenheim in a report issued on Monday,Benzinga reports. They currently have a $25.00 price objective on the stock. Guggenheim’s price target indicates a potential upside of 146.06% from the company’s previous close. A number of other equities analysts have […] - 2025-08-27 02:08:53
Wedbush Comments on Immunome’s Q3 Earnings (NASDAQ:IMNM)
Immunome, Inc. (NASDAQ:IMNM – Free Report) – Equities research analysts at Wedbush reduced their Q3 2025 earnings per share (EPS) estimates for Immunome in a report issued on Thursday, August 7th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of ($0.50) for the quarter, down from their previous forecast […] - 2025-08-12 03:02:57
Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Alps Advisors Inc.
Alps Advisors Inc. increased its holdings in Immunome, Inc. (NASDAQ:IMNM – Free Report) by 23.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 62,544 shares of the company’s stock after buying an additional 12,074 shares during the period. Alps Advisors Inc. owned about 0.07% of Immunome […] - 2025-07-15 06:26:33
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of “Buy” by Analysts
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has earned a consensus recommendation of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in […] - 2025-06-24 02:52:58
Two Sigma Investments LP Makes New Investment in Immunome, Inc. (NASDAQ:IMNM)
Two Sigma Investments LP bought a new stake in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 154,467 shares of the company’s stock, valued at approximately $1,640,000. A number of other institutional investors […] - 2025-06-03 06:04:56
Voya Investment Management LLC Sells 1,439 Shares of Immunome, Inc. (NASDAQ:IMNM)
Voya Investment Management LLC cut its holdings in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) by 8.4% in the 4th quarter, HoldingsChannel reports. The fund owned 15,600 shares of the company’s stock after selling 1,439 shares during the period. Voya Investment Management LLC’s holdings in Immunome were worth $166,000 as of its most recent […] - 2025-05-15 04:49:04
Immunome (NASDAQ:IMNM) Shares Gap Up After Strong Earnings
Immunome, Inc. (NASDAQ:IMNM – Get Free Report)’s share price gapped up prior to trading on Tuesday following a stronger than expected earnings report. The stock had previously closed at $7.94, but opened at $8.37. Immunome shares last traded at $8.06, with a volume of 74,171 shares. The company reported ($0.52) earnings per share (EPS) for […] - 2025-05-15 02:18:50
MetLife Investment Management LLC Purchases 5,354 Shares of Immunome, Inc. (NASDAQ:IMNM)
MetLife Investment Management LLC increased its holdings in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) by 17.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 35,619 shares of the company’s stock after acquiring an additional 5,354 shares during the quarter. MetLife Investment Management LLC’s holdings in Immunome were worth $378,000 at the […] - 2025-05-07 06:00:48
Barclays PLC Sells 1,572 Shares of Immunome, Inc. (NASDAQ:IMNM)
Barclays PLC decreased its position in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) by 1.5% in the 4th quarter, HoldingsChannel reports. The firm owned 104,314 shares of the company’s stock after selling 1,572 shares during the quarter. Barclays PLC’s holdings in Immunome were worth $1,107,000 at the end of the most recent reporting period. […] - 2025-05-05 05:26:54
Brokerages Set Immunome, Inc. (NASDAQ:IMNM) Target Price at $25.33
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have issued a report on the stock in […] - 2025-05-05 03:14:50
Renaissance Technologies LLC Purchases 304,700 Shares of Immunome, Inc. (NASDAQ:IMNM)
Renaissance Technologies LLC increased its position in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) by 2,696.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 316,000 shares of the company’s stock after acquiring an additional 304,700 shares during the […] - 2025-04-24 04:50:55
JPMorgan Chase & Co. Has $6.89 Million Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)
JPMorgan Chase & Co. raised its holdings in Immunome, Inc. (NASDAQ:IMNM – Free Report) by 2,540.4% in the 4th quarter, HoldingsChannel reports. The fund owned 648,610 shares of the company’s stock after acquiring an additional 624,045 shares during the period. JPMorgan Chase & Co.’s holdings in Immunome were worth $6,888,000 at the end of the […] - 2025-04-17 04:27:20
Corient Private Wealth LLC Sells 12,149 Shares of Immunome, Inc. (NASDAQ:IMNM)
Corient Private Wealth LLC trimmed its position in Immunome, Inc. (NASDAQ:IMNM – Free Report) by 50.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 12,085 shares of the company’s stock after selling 12,149 shares during the period. Corient Private Wealth LLC’s holdings in Immunome were worth […] - 2025-04-02 04:22:52
Immunome, Inc. (NASDAQ:IMNM) Holdings Increased by Intech Investment Management LLC
Intech Investment Management LLC increased its stake in Immunome, Inc. (NASDAQ:IMNM – Free Report) by 26.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,961 shares of the company’s stock after acquiring an additional 3,974 shares during the period. Intech […] - 2025-03-27 06:03:10
Immunome, Inc. (NASDAQ:IMNM) Shares Purchased by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC grew its position in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) by 11.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 19,065 shares of the company’s stock after purchasing an additional 2,000 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Immunome were worth $202,000 as of its […] - 2025-03-21 06:24:53
AlphaQuest LLC Raises Stock Position in Immunome, Inc. (NASDAQ:IMNM)
AlphaQuest LLC grew its stake in shares of Immunome, Inc. (NASDAQ:IMNM – Free Report) by 786,700.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,868 shares of the company’s stock after acquiring an additional 7,867 shares during the […] - 2025-03-19 06:20:57
Immunome (NASDAQ:IMNM) Now Covered by Lifesci Capital
Investment analysts at Lifesci Capital assumed coverage on shares of Immunome (NASDAQ:IMNM – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $20.00 price target on the stock. Lifesci Capital’s price objective suggests a potential upside of 117.16% from the company’s current […] - 2025-03-13 05:08:48
Immunome (NASDAQ:IMNM) Shares Gap Up on Insider Buying Activity
Immunome, Inc. (NASDAQ:IMNM – Get Free Report)’s stock price gapped up prior to trading on Tuesday following insider buying activity. The stock had previously closed at $10.32, but opened at $11.16. Immunome shares last traded at $10.87, with a volume of 472,104 shares trading hands. Specifically, CEO Clay B. Siegall purchased 150,000 shares of the […] - 2025-02-06 04:10:43

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc IMNM holdings

DateNumber of IMNM Shares HeldBase Market Value of IMNM SharesLocal Market Value of IMNM SharesChange in IMNM Shares HeldChange in IMNM Base ValueCurrent Price per IMNM Share HeldPrevious Price per IMNM Share Held
2025-11-13 (Thursday)48,873USD 806,893USD 806,893
2025-11-12 (Wednesday)48,873IMNM holding decreased by -160USD 851,856IMNM holding decreased by -7202USD 851,856-160USD -7,202 USD 17.43 USD 17.52
2025-11-11 (Tuesday)49,033USD 859,058IMNM holding increased by 52955USD 859,0580USD 52,955 USD 17.52 USD 16.44
2025-11-10 (Monday)49,033USD 806,103IMNM holding increased by 58840USD 806,1030USD 58,840 USD 16.44 USD 15.24
2025-11-07 (Friday)49,033USD 747,263IMNM holding decreased by -12749USD 747,2630USD -12,749 USD 15.24 USD 15.5
2025-11-06 (Thursday)49,033IMNM holding decreased by -160USD 760,012IMNM holding increased by 4899USD 760,012-160USD 4,899 USD 15.5 USD 15.35
2025-11-05 (Wednesday)49,193IMNM holding decreased by -1600USD 755,113IMNM holding decreased by -27607USD 755,113-1,600USD -27,607 USD 15.35 USD 15.41
2025-11-04 (Tuesday)50,793IMNM holding decreased by -320USD 782,720IMNM holding decreased by -86201USD 782,720-320USD -86,201 USD 15.41 USD 17
2025-11-03 (Monday)51,113IMNM holding decreased by -320USD 868,921IMNM holding increased by 42393USD 868,921-320USD 42,393 USD 17 USD 16.07
2025-10-31 (Friday)51,433USD 826,528IMNM holding increased by 4629USD 826,5280USD 4,629 USD 16.07 USD 15.98
2025-10-30 (Thursday)51,433USD 821,899IMNM holding increased by 11315USD 821,8990USD 11,315 USD 15.98 USD 15.76
2025-10-29 (Wednesday)51,433USD 810,584IMNM holding decreased by -32403USD 810,5840USD -32,403 USD 15.76 USD 16.39
2025-10-28 (Tuesday)51,433IMNM holding increased by 480USD 842,987IMNM holding decreased by -2833USD 842,987480USD -2,833 USD 16.39 USD 16.6
2025-10-27 (Monday)50,953USD 845,820IMNM holding increased by 46367USD 845,8200USD 46,367 USD 16.6 USD 15.69
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IMNM by Blackrock for IE00B3VWM098

Show aggregate share trades of IMNM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-16017.94017.060 17.148USD -2,744 10.30 Loss of -1,096 on sale
2025-11-06SELL-16015.84015.260 15.318USD -2,451 10.18 Loss of -823 on sale
2025-11-05SELL-1,60015.81014.710 14.820USD -23,712 10.15 Loss of -7,475 on sale
2025-11-04SELL-32016.80015.060 15.234USD -4,875 10.12 Loss of -1,636 on sale
2025-11-03SELL-32017.87015.820 16.025USD -5,128 10.08 Loss of -1,901 on sale
2025-10-28BUY48016.39016.970 16.912USD 8,118 9.96
2025-10-24SELL-16015.69016.400 16.329USD -2,613 9.89 Loss of -1,031 on sale
2025-10-15BUY96016.35016.400 16.395USD 15,739 9.64
2025-10-02BUY16011.47011.625 11.610USD 1,858 9.61
2025-09-30BUY32011.71011.820 11.809USD 3,779 9.59
2025-08-21SELL-2009.9509.960 9.959USD -1,992 9.56 Loss of -79 on sale
2025-07-31BUY60010.52010.780 10.754USD 6,452 9.56
2025-06-30SELL-4009.3009.315 9.313USD -3,725 9.54 Profit of 90 on sale
2025-06-25SELL-2008.6808.950 8.923USD -1,785 9.56 Profit of 127 on sale
2025-06-20SELL-4008.7508.950 8.930USD -3,572 9.57 Profit of 257 on sale
2025-05-30SELL-10,5468.7608.895 8.882USD -93,664 9.62 Profit of 7,773 on sale
2025-05-23BUY2378.4908.520 8.517USD 2,019 9.66
2025-05-19SELL-2378.0108.440 8.397USD -1,990 9.71 Profit of 311 on sale
2025-05-15SELL-7118.0008.090 8.081USD -5,746 9.74 Profit of 1,178 on sale
2025-05-12SELL-2377.9408.100 8.084USD -1,916 9.79 Profit of 404 on sale
2025-05-09SELL-2377.4608.013 7.958USD -1,886 9.81 Profit of 438 on sale
2025-04-30SELL-2378.7908.940 8.925USD -2,115 9.91 Profit of 234 on sale
2025-04-24SELL-4748.5208.879 8.843USD -4,192 9.97 Profit of 534 on sale
2025-04-22BUY10,2048.1908.360 8.343USD 85,132 10.00
2025-04-17SELL-2027.9107.960 7.955USD -1,607 10.07 Profit of 427 on sale
2025-04-15SELL-6067.4007.480 7.472USD -4,528 10.13 Profit of 1,611 on sale
2025-04-14SELL-6067.3507.563 7.542USD -4,570 10.16 Profit of 1,587 on sale
2025-04-09SELL-8126.2106.304 6.295USD -5,111 10.29 Profit of 3,241 on sale
2025-04-07SELL-1,4215.8806.135 6.110USD -8,682 10.39 Profit of 6,085 on sale
2025-04-04SELL-2,0305.9306.200 6.173USD -12,531 10.44 Profit of 8,670 on sale
2025-03-31BUY2036.7306.855 6.843USD 1,389 10.59
2025-03-19SELL-4068.5708.710 8.696USD -3,531 10.89 Profit of 893 on sale
2025-03-14SELL-1,2188.7709.160 9.121USD -11,109 10.99 Profit of 2,272 on sale
2025-03-13SELL-4088.9309.490 9.434USD -3,849 11.02 Profit of 645 on sale
2025-03-12SELL-6,9369.2109.340 9.327USD -64,692 11.04 Profit of 11,893 on sale
2025-03-07SELL-4089.3409.530 9.511USD -3,880 11.14 Profit of 663 on sale
2025-03-06SELL-6129.2209.420 9.400USD -5,753 11.17 Profit of 1,080 on sale
2025-03-03SELL-2048.9409.535 9.475USD -1,933 11.27 Profit of 365 on sale
2025-02-28BUY17,8249.4009.440 9.436USD 168,187 11.30
2025-02-26SELL-1549.5809.970 9.931USD -1,529 11.37 Profit of 221 on sale
2025-02-25SELL-4629.6709.910 9.886USD -4,567 11.40 Profit of 698 on sale
2025-02-18BUY7709.93010.681 10.606USD 8,167 11.55
2025-02-13BUY15410.43010.530 10.520USD 1,620 11.62
2025-02-12BUY12,47510.40010.420 10.418USD 129,965 11.64
2025-02-11BUY36310.27011.180 11.089USD 4,025 11.67
2025-02-06BUY1,08911.43011.949 11.897USD 12,956 11.71
2025-01-27BUY1219.69010.360 10.293USD 1,245 11.99
2024-12-30BUY60010.28010.570 10.541USD 6,325 12.20
2024-12-06BUY48013.73013.839 13.828USD 6,637 12.02
2024-12-05BUY12012.70013.630 13.537USD 1,624 11.99
2024-12-04BUY60013.54014.090 14.035USD 8,421 11.94
2024-11-29BUY60013.55013.660 13.649USD 8,189 11.73
2024-11-27BUY48013.47013.530 13.524USD 6,492 11.57
2024-11-26BUY12011.53011.810 11.782USD 1,414 11.58
2024-11-21BUY6009.4209.712 9.683USD 5,810 11.80
2024-11-20BUY3609.3309.360 9.357USD 3,369 11.94
2024-11-18BUY1,4409.43510.200 10.123USD 14,578 12.26
2024-11-12BUY96012.49013.085 13.026USD 12,504 12.24
2024-11-08BUY60012.98013.470 13.421USD 8,053 12.19
2024-11-07BUY1,80012.54013.630 13.521USD 24,338 12.16
2024-11-06BUY24013.10013.660 13.604USD 3,265 12.08
2024-10-31BUY12011.47012.080 12.019USD 1,442 12.02
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IMNM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19507,1141,963639,22079.3%
2025-09-18439,8190766,87957.4%
2025-09-17218,6390401,85554.4%
2025-09-16183,9140340,59254.0%
2025-09-15247,0152,399428,80757.6%
2025-09-124,548,75204,682,01197.2%
2025-09-11296,6750355,32183.5%
2025-09-10273,0650387,60270.4%
2025-09-09562,61425,606833,97967.5%
2025-09-08392,141316581,10967.5%
2025-09-05185,4051,950508,49536.5%
2025-09-04176,6700273,59364.6%
2025-09-03305,720206459,12366.6%
2025-09-02114,98695194,95759.0%
2025-08-29236,9380264,80089.5%
2025-08-28105,6550136,80977.2%
2025-08-27165,2770202,68981.5%
2025-08-26150,5140680,10122.1%
2025-08-25172,3410238,38372.3%
2025-08-22261,9170371,59170.5%
2025-08-2166,407097,30668.2%
2025-08-20115,3569,047202,39857.0%
2025-08-19103,4400152,26167.9%
2025-08-1893,250325137,01168.1%
2025-08-1595,9380210,61545.6%
2025-08-1491,961300163,72256.2%
2025-08-13147,1940257,68557.1%
2025-08-1278,8760161,12449.0%
2025-08-1189,696438134,37766.7%
2025-08-08135,720366239,09156.8%
2025-08-07301,41594402,84974.8%
2025-08-06128,2770203,48163.0%
2025-08-05164,646122239,55968.7%
2025-08-0498,88094142,39669.4%
2025-08-01164,153224221,41374.1%
2025-07-31122,569142200,93861.0%
2025-07-30148,803524177,32783.9%
2025-07-29172,47647330,09652.3%
2025-07-28191,894500230,59283.2%
2025-07-25144,581126245,68958.8%
2025-07-24162,084228248,20565.3%
2025-07-23227,3354362,24462.8%
2025-07-22170,31050248,38268.6%
2025-07-21129,015108215,09260.0%
2025-07-18305,799417437,70869.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.